Leadiant Biosciences recalls
FDA enforcement reports naming LEADIANT BIOSCIENCES, INC as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 0
- Most recent report
- Feb 22, 2023
- Feb 22, 2023Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufa…Drug · Leadiant Biosciences, Inc.Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.Class II
- Oct 21, 2020Cystaran (cysteamine ophthalmic solution) 0Drug · Leadiant Biosciences, Inc.Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.Class III
- Apr 25, 2018Cystaran (cysteamine ophthalmic solution) 0Drug · LEADIANT BIOSCIENCES, INCSubpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.Class III
- Mar 7, 2018Cystaran (cysteamine ophthalmic solution) 0Drug · LEADIANT BIOSCIENCES, INCSubpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.Class III